|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02659 BAO PHARMA-B
Nominal 
89.800 -2.400 (-2.603%) Non-current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |
| Investment Properties | -- | -- | 0 | 0 |
| Property, plant, equip. & others | -- | -- | 621,681 | 531,215 |
| Land & other Lease Assets | -- | -- | 55,451 | 54,207 |
| Intangible Assets | -- | -- | 12,317 | 12,565 |
| Interests in Asso. & JCEs | -- | -- | 7,828 | 8,437 |
| Other Non-current Assets | -- | -- | 410 | 1,311 |
| -- | -- | 697,687 | 607,735 | |
Current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | ||
| Inventories | -- | -- | 4,715 | 8,072 | |
| Trade Receivables | -- | -- | 141 | 2,000 | |
| Cash & Bank Balances | -- | -- | 524,158 | 321,671 | |
| Other Current Assets | -- | -- | 136,566 | 34,402 | |
| Assets Held for Sale | -- | -- | 0 | 0 | |
| -- | -- | 665,580 | 366,145 | ||
Current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |||
| Trade Payables | -- | -- | 0 | 0 | ||
| S-T Debt & Leases | -- | -- | 71,129 | 66,035 | ||
| Other Current Liabilities | -- | -- | 125,102 | 80,786 | ||
| Liab asso w/ Assets Held for Sale | -- | -- | 0 | 0 | ||
| -- | -- | 196,231 | 146,821 | |||
| Net Current Assets | -- | -- | 469,349 | 219,324 | ||
| Total Assets Less Current Liabilities | -- | -- | 1,167,036 | 827,059 | ||
Non-current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | ||||
| L-T Debt & Leases | -- | -- | 134,130 | 45,080 | |||
| Other Non-current Liabilities | -- | -- | 37,030 | 32,853 | |||
| -- | -- | 171,160 | 77,933 | ||||
Capital and Reserves
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |||||
| Share Capital | -- | -- | 57,259 | 52,046 | ||||
| Reserves | -- | -- | 938,617 | 697,080 | ||||
| Others | -- | -- | 0 | 0 | ||||
| Shareholders' Funds | -- | -- | 995,876 | 749,126 | ||||
| Non-controlling Interests | -- | -- | 0 | 0 | ||||
| Others | -- | -- | 0 | 0 | ||||
| -- | -- | 995,876 | 749,126 | |||||
Commitments and Contingent Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |
| Commitments | -- | -- | 82,001 | 101,880 |
| Contingent Liabilities | -- | -- | 0 | 0 |
| Remarks: | Real time quote last updated: 27/03/2026 16:41 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -395,302 |
| %Change | 8.470% |
| EPS / (LPS) | RMB -1.360 |
| NBV Per Share (¥) | RMB -- |